Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

Fig. 6

In-vivo efficacy of MFU in PDX mouse model and chronic toxicity. (a) Tumor growth curves of GemHCl and MFU treated mice bearing pancreatic PDX tumor and (b) body weight during treatment. (e) Percent change in the body weight of mice over the study period. Asterisks represents level of significance between control and treatment group (**p < 0.05, ***p < 0.001). All data represents mean ± SD, (n = 4/group)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us